Social implication, economic aspects and new abilities of strontium ranelate in pharmacotherapy for postmenopausal osteoporosis

The authors have analyzed the efficiency of and clinicoeconomic prospects for the use of strontium ranelate, by taking account epidemiological data and management costs for postmenopausal osteoporosis (OP). Strontium ranelate both stimulates the formulation of bone tissue and suppresses its resorpti...

Full description

Bibliographic Details
Main Authors: I S Dydykina, A V Bykov, V V Tsurko
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2008-09-01
Series:Современная ревматология
Online Access:https://mrj.ima-press.net/mrj/article/view/174
id doaj-a4284031cb93488d81bcad996cfd38b8
record_format Article
spelling doaj-a4284031cb93488d81bcad996cfd38b82021-07-29T09:00:05ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2008-09-0123505410.14412/1996-7012-2008-4891479Social implication, economic aspects and new abilities of strontium ranelate in pharmacotherapy for postmenopausal osteoporosisI S DydykinaA V BykovV V TsurkoI S DydykinaA V BykovV V TsurkoThe authors have analyzed the efficiency of and clinicoeconomic prospects for the use of strontium ranelate, by taking account epidemiological data and management costs for postmenopausal osteoporosis (OP). Strontium ranelate both stimulates the formulation of bone tissue and suppresses its resorption, by generating a new bone tissue and ensuring early and long-term prevention of fractures. It is noted that strontium ranelate is now the only drug for the treatment of OP, by physiologically affecting bone metabolism. Furthermore, it is an agent with proved efficacy in OP patients over 80 years of age. The authors show that it is clinically and economically expedient to use strontiumhttps://mrj.ima-press.net/mrj/article/view/174
collection DOAJ
language Russian
format Article
sources DOAJ
author I S Dydykina
A V Bykov
V V Tsurko
I S Dydykina
A V Bykov
V V Tsurko
spellingShingle I S Dydykina
A V Bykov
V V Tsurko
I S Dydykina
A V Bykov
V V Tsurko
Social implication, economic aspects and new abilities of strontium ranelate in pharmacotherapy for postmenopausal osteoporosis
Современная ревматология
author_facet I S Dydykina
A V Bykov
V V Tsurko
I S Dydykina
A V Bykov
V V Tsurko
author_sort I S Dydykina
title Social implication, economic aspects and new abilities of strontium ranelate in pharmacotherapy for postmenopausal osteoporosis
title_short Social implication, economic aspects and new abilities of strontium ranelate in pharmacotherapy for postmenopausal osteoporosis
title_full Social implication, economic aspects and new abilities of strontium ranelate in pharmacotherapy for postmenopausal osteoporosis
title_fullStr Social implication, economic aspects and new abilities of strontium ranelate in pharmacotherapy for postmenopausal osteoporosis
title_full_unstemmed Social implication, economic aspects and new abilities of strontium ranelate in pharmacotherapy for postmenopausal osteoporosis
title_sort social implication, economic aspects and new abilities of strontium ranelate in pharmacotherapy for postmenopausal osteoporosis
publisher IMA-PRESS LLC
series Современная ревматология
issn 1996-7012
2310-158X
publishDate 2008-09-01
description The authors have analyzed the efficiency of and clinicoeconomic prospects for the use of strontium ranelate, by taking account epidemiological data and management costs for postmenopausal osteoporosis (OP). Strontium ranelate both stimulates the formulation of bone tissue and suppresses its resorption, by generating a new bone tissue and ensuring early and long-term prevention of fractures. It is noted that strontium ranelate is now the only drug for the treatment of OP, by physiologically affecting bone metabolism. Furthermore, it is an agent with proved efficacy in OP patients over 80 years of age. The authors show that it is clinically and economically expedient to use strontium
url https://mrj.ima-press.net/mrj/article/view/174
work_keys_str_mv AT isdydykina socialimplicationeconomicaspectsandnewabilitiesofstrontiumranelateinpharmacotherapyforpostmenopausalosteoporosis
AT avbykov socialimplicationeconomicaspectsandnewabilitiesofstrontiumranelateinpharmacotherapyforpostmenopausalosteoporosis
AT vvtsurko socialimplicationeconomicaspectsandnewabilitiesofstrontiumranelateinpharmacotherapyforpostmenopausalosteoporosis
AT isdydykina socialimplicationeconomicaspectsandnewabilitiesofstrontiumranelateinpharmacotherapyforpostmenopausalosteoporosis
AT avbykov socialimplicationeconomicaspectsandnewabilitiesofstrontiumranelateinpharmacotherapyforpostmenopausalosteoporosis
AT vvtsurko socialimplicationeconomicaspectsandnewabilitiesofstrontiumranelateinpharmacotherapyforpostmenopausalosteoporosis
_version_ 1721250429139943424